Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SOS Carbon is a marine biotechnology company focused on managing the sargassum seaweed crisis through innovative collection and sequestration technologies. Spun off from the Massachusetts Institute of Technology (MIT), the company utilizes its proprietary Littoral Collection Module (LCM) to intercept sargassum at sea before it reaches shorelines, preventing environmental and economic damage. The harvested biomass is then utilized for carbon sequestration or processed into high-value organic products like liquid fertilizers. By transforming an environmental hazard into a sustainable resource, SOS Carbon provides a scalable solution for ocean health and climate change mitigation. The company's operations are primarily centered in the Caribbean, where sargassum blooms significantly impact tourism and local ecosystems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SOS Carbon.